Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Gargle sample is an effective option in a novel fully automated molecular point-of-care test for influenza: a multicenter study

View ORCID ProfileNorihito Kaku, Tomohito Urabe, Tetsuya Iida, Chyuns Yun, Yoshiyuki Nishida, Yasunori Onitsuka, Kohji Hashiguchi, Kiyoto Hirose, Akimitsu Tomonaga, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara
doi: https://doi.org/10.1101/2022.06.03.22275936
Norihito Kaku
aDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan
bDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan
cDivision of Pulmonary & Critical Care Medicine, University of Michigan, Michigan, Ann Arbor, Michigan, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Norihito Kaku
  • For correspondence: norihitk{at}gmail.com
Tomohito Urabe
dUrabe Otorhinolaryngology Clinic, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuya Iida
eIida Naika Syounika Clinic, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chyuns Yun
fOhisama Pediatric Clinic, Nagayo-cho, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiyuki Nishida
gNishida Gastrointestinal Internal Medicine Clinic, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasunori Onitsuka
hOnitsuka Internal Medicine Clinic, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohji Hashiguchi
iDepartment of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyoto Hirose
jHirose Clinic, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akimitsu Tomonaga
kTomonaga Medical Clinic, Omura City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichi Izumikawa
lDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Mukae
mDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsunori Yanagihara
aDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan
bDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background We conducted a multicenter study to evaluate the performance of a novel fully automated molecular point-of-care test using transcription-reverse transcription concerted reaction that can detect influenza A and B within 15 minutes in nasopharyngeal swabs and gargle samples (TRCsatFLU).

Methods Patients who visited or were hospitalized at eight clinics and hospitals with influenza-like illnesses between December 2019 and March 2020 participated in this study. We collected nasopharyngeal swabs from all patients and gargle samples from patients whom the physician judged fit to perform gargling. The result of TRCsatFLU was compared to a conventional reverse transcription-polymerase chain reaction (RT-PCR). If the results of TRCsatFLU and conventional RT-PCR were different, the samples were analyzed by sequencing.

Results We evaluated 233 nasopharyngeal swabs and 213 gargle samples from 244 patients.. The average age of the patients was 39.3 ± 21.2. Of the patients, 68.9% visited a hospital within 24 h of symptom onset. The most common symptoms were fever (93.0%), fatigue (79.5%), and nasal discharge (64.8%). All patients in whom the gargle sample was not collected were children. Influenza A or B was detected in 98 and 99 patients in nasopharyngeal swabs and gargle samples using TRCsatFLU, respectively. Four and five patients in nasopharyngeal swabs and gargle samples, respectively, with different TRCsatFLU and conventional RT-PCR results. Influenza A or B was detected using sequencing in all samples with different results. Based on the combined conventional RT-PCR and sequencing results, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of TRCsatFLU for influenza detection in nasopharyngeal swabs were 0.990, 1.000, 1.000, and 0.993, respectively. In the gargle samples, the sensitivity, specificity, PPV, and NPV of the TRCsatFLU for detecting influenza were 0.971, 1.000, 1.000, and 0.974, respectively.

Conclusions The TRCsatFLU showed great sensitivity and specificity for the detection of influenza in nasopharyngeal swabs and gargle samples.

Trial registration This study was registered in the UMIN Clinical Trials Registry (reference number: UMIN000038276) on October 11, 2019. Before sample collection, written informed consent for the participation and publication of this study was obtained from all participants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Tosoh Corporation funded the study. The sponsor performed RT-PCR, TRC, and sequencing for influenza, but had no control over the interpretation, writing, or publication of this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the ethics committee of Nagasaki University Hospital (approval number:19121603) and registered in the UMIN Clinical Trials Registry (reference number: UMIN000038276). Before sample collection, written informed consent for the participation and publication of this study was obtained from all participants.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Revised the entire paper

Data Availability

The derived data supporting the findings of this study are presented in this paper, supplementary Table1 and 2, and metadata file.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Gargle sample is an effective option in a novel fully automated molecular point-of-care test for influenza: a multicenter study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Gargle sample is an effective option in a novel fully automated molecular point-of-care test for influenza: a multicenter study
Norihito Kaku, Tomohito Urabe, Tetsuya Iida, Chyuns Yun, Yoshiyuki Nishida, Yasunori Onitsuka, Kohji Hashiguchi, Kiyoto Hirose, Akimitsu Tomonaga, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara
medRxiv 2022.06.03.22275936; doi: https://doi.org/10.1101/2022.06.03.22275936
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Gargle sample is an effective option in a novel fully automated molecular point-of-care test for influenza: a multicenter study
Norihito Kaku, Tomohito Urabe, Tetsuya Iida, Chyuns Yun, Yoshiyuki Nishida, Yasunori Onitsuka, Kohji Hashiguchi, Kiyoto Hirose, Akimitsu Tomonaga, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara
medRxiv 2022.06.03.22275936; doi: https://doi.org/10.1101/2022.06.03.22275936

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)